cmAngio® vs CAC Software

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CureMetrix
VS
by 4DMedical (Imbio CAC Software)

AI Verdict

Tool A detects Breast Arterial Calcifications (BAC) on mammograms for cardiovascular health insights, whereas Tool B quantifies Coronary Artery Calcification (CAC) from chest CT scans to assess coronary artery disease risk. While both contribute to cardiovascular risk assessment through calcification analysis, they utilize different imaging modalities and focus on distinct anatomical locations, making them complementary tools for different clinical workflows.

Choose cmAngio® if…

Choose cmAngio® if your primary goal is to leverage existing mammography screenings to gain insights into a woman's cardiovascular health without additional radiation exposure. This tool is ideal for integrating early cardiovascular risk assessment into routine breast imaging workflows by identifying Breast Arterial Calcifications (BAC).

View cmAngio® →

Choose CAC Software if…

Choose Imbio's CAC Software if you require a precise, quantitative assessment of coronary artery calcification using non-contrast chest CT scans. This tool is best suited for cardiologists and radiologists needing detailed Agatston scores and 3D visualizations to stratify a patient's risk for coronary artery disease.

View CAC Software →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature cmAngio® CAC Software
Pricing Paid, out-of-pocket Unknown
Deployment Cloud-based, integrates with any DICOM-compliant viewer Cloud-based (SaaS), integrates with PACS
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

cmAngio®

Tool A explicitly highlights 'quick and easy installation (less than an hour)' and an 'adjustable operating point to meet clinical goals,' suggesting a strong focus on user experience and adaptability. While both integrate into existing DICOM workflows, Tool A's specific claims indicate a potentially smoother initial setup and more customizable ongoing use.

Clinical Value

CAC Software

Tool B provides automated quantification of Coronary Artery Calcification (CAC) with established metrics like the Agatston score, which is a widely recognized and direct indicator of coronary artery disease risk. While Tool A offers valuable insights from Breast Arterial Calcifications (BAC) on mammograms, the direct clinical utility and established risk stratification of CAC scoring make Tool B's offering slightly more impactful in current cardiology practice.

Pricing & Value

Tie

Both tools require direct contact for pricing, making a transparent comparison of value difficult. While Tool A mentions 'limited-time offers for no-cost implementation and service' which could offer a better initial value, without concrete pricing details for either, it is impossible to definitively pick a winner.

Enterprise Readiness

CAC Software

Tool B offers more flexible deployment options including Cloud, On-premise, and Partner platforms, and explicitly states it has a Business Associate Agreement (BAA). Tool A's deployment is inferred as cloud-based, and BAA status requires contacting the vendor, making Tool B's enterprise integration capabilities more clearly defined and adaptable for various IT infrastructures.

Innovation

cmAngio®

Tool A demonstrates innovation by leveraging existing mammography data to detect Breast Arterial Calcifications (BAC), providing a novel approach to cardiovascular risk assessment from a commonly performed screening exam. While Tool B offers advanced automation for CAC scoring, Tool A's cross-disciplinary application of AI to extract new value from existing imaging for a different health domain is arguably more innovative.

Support & Docs

Tie

Neither the provided structured facts nor general web searches yielded specific details regarding the depth or availability of support and documentation for either product. Both companies generally mention customer support, but without specifics, it is impossible to differentiate between them.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature cmAngio® CAC Software
Primary Target/Biomarker Breast Arterial Calcifications (BAC) Coronary Artery Calcification (CAC)
Imaging Modality Used Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams Non-contrast, chest computed tomography (CT)
Key Outputs/Metrics Provided Visualization of BAC location on a scorecard, BAC identification and reporting Agatston score, arterial age, calcified lesion mass and volume, 3D visualizations and annotated images
Supported Medical Specialties Cardiology, Obstetrics & Gynecology, Radiology Cardiology, Radiology
Installation Time Quick and easy installation (less than an hour) Not specified

Videos

Demos, reviews, and walkthroughs featuring cmAngio® and CAC Software.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

cmAngiou00ae by CureMetrix analyzes Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams for Breast Arterial Calcifications (BAC). Imbio's CAC Software processes non-contrast chest computed tomography (CT) scans to assess Coronary Artery Calcification (CAC).
cmAngiou00ae provides visualization of BAC location on a scorecard, enabling identification and reporting of these calcifications. Imbio's CAC Software outputs quantitative data such as Agatston score, arterial age, calcified lesion mass, and volume, along with 3D visualizations and annotated images.
cmAngiou00ae is relevant for Cardiology, Obstetrics & Gynecology, and Radiology, focusing on women's cardiovascular health insights from mammograms. Imbio's CAC Software is primarily for Cardiology and Radiology, aiding in risk assessment for coronary artery disease from CT scans.
cmAngiou00ae enables BAC identification and reporting without additional radiation or procedures, utilizing existing mammogram data. Imbio's CAC Software performs non-invasive analysis from existing non-contrast chest CT scans, which are already part of a patient's diagnostic imaging.
cmAngiou00ae provides insights into cardiovascular health and aids in early risk assessment by detecting BAC on mammograms. Imbio's CAC Software supports risk assessment for coronary artery disease by quantifying calcification within coronary arteries from CT scans.

Backers

Who funded each tool's parent company.

cmAngio®

AI Tool Finder
AI-powered search. Results may not be comprehensive.